1. Home
  2. AXGN vs IRON Comparison

AXGN vs IRON Comparison

Compare AXGN & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Axogen Inc.

AXGN

Axogen Inc.

HOLD

Current Price

$44.49

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

HOLD

Current Price

$73.35

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AXGN
IRON
Founded
N/A
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.6B
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
AXGN
IRON
Price
$44.49
$73.35
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
11
Target Price
$42.33
$103.18
AVG Volume (30 Days)
1.2M
533.7K
Earning Date
04-28-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$225,208,000.00
N/A
Revenue This Year
$20.57
N/A
Revenue Next Year
$16.68
$283.52
P/E Ratio
N/A
N/A
Revenue Growth
20.21
N/A
52 Week Low
$10.50
$40.00
52 Week High
$46.00
$99.50

Technical Indicators

Market Signals
Indicator
AXGN
IRON
Relative Strength Index (RSI) 57.98 63.17
Support Level $29.48 $70.29
Resistance Level $44.83 $82.70
Average True Range (ATR) 2.34 2.87
MACD 0.05 0.30
Stochastic Oscillator 71.81 90.74

Price Performance

Historical Comparison
AXGN
IRON

About AXGN Axogen Inc.

Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

Share on Social Networks: